News & Updates
Filter by Specialty:
New chemo-free triplet regimen shows promise for endometrial cancer
A triplet regimen combining the PARP inhibitor olaparib with metronomic cyclophosphamide and metformin showed favourable signals for heavily pretreated women with advanced endometrial carcinoma, the phase I/II ENDOLA study suggests.
New chemo-free triplet regimen shows promise for endometrial cancer
09 May 2022What drives persistent distress in COVID-19 frontliners?
Frontline nurses in Singapore and Japan are at risk of prolonged psychological distress after caring for COVID-19 patients, according to a recent study. Such distress also persists in healthcare workers who have underlying medical conditions or who have dealt with an outbreak in the hospital.
What drives persistent distress in COVID-19 frontliners?
09 May 2022AChEIs and memantine cost-effective, offer improvements in AD
A systematic review and meta-analysis of Alzheimer’s disease (AD) therapies’ cost-effectiveness carried out by researchers from the Chinese University of Hong Kong (CUHK) identifies acetylcholinesterase inhibitors (AChEIs) and memantine as cost-effective and offering improvements in dementia-related symptoms.